Related Experiment Video
Updated: Jul 15, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte
Jing Xu1, Xinlu Wang1, Qinjie Weng1
1Department of Nephrology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Background:
Membranous nephropathy (MN) is a major pattern of nephrotic syndrome (NS) in adults. Some MN have secondary causes and some may be accompanied with other glomerular diseases. MN patients coexisting with amyloidosis are very rare, and mostly was polytypic MN. Herein, we describe the first report which identifying monotype PLA2R-MN (κ light chain) concurrent with leukocyte chemotactic factor 2 amyloidosis (ALECT2). This rare case highlights the importance of renal pathology for diagnosis.
Case Presentation:
We describe a case of a 60-year-old male patient with persistent proteinuria and low serum albumin for nine months. No monoclonal component was revealed by serum and urine immunofixation electrophoresis but serum PLA2R antibody was positive. The patient was empirically treated with Leflunomide and Losartan, but edema was not improved. The diagnosis of renal pathology is PLA2R-related monotypic (IgG-κ positive) MN concurrent with ALECT2. Methylprednisolone, cyclosporine A and anticoagulant (rivaroxaban) were prescribed resulting in a complete remission of NS.
Conclusions:
MN patients concurrent with ALECT2 presented massive proteinuria or NS. When nephrotic range proteinuria is present in ALECT2, it is important to consider that it may be due to a concomitant underlying nephropathy especially MN and treated according to MN will get good therapeutic effect.
Insights
This study reports the first case of monotypic phospholipase A2 receptor-associated membranous nephropathy (PLA2R-MN) co-occurring with leukocyte chemotactic factor 2 amyloidosis (ALECT2). Prompt renal pathology diagnosis and treatment for MN led to complete remission of nephrotic syndrome.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- Membranous nephropathy (MN) is a leading cause of nephrotic syndrome (NS) in adults.
- Co-occurrence of MN with amyloidosis is rare, typically presenting as polytypic MN.
- This report details the first identified case of monotypic PLA2R-MN with leukocyte chemotactic factor 2 amyloidosis (ALECT2).
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management